Trial Profile
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Design, Prospective, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Donepezil and Combined With GV1001 in Alzheimer Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Tertomotide (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors KAEL-GemVax
- 30 Mar 2021 Results published in the GemVax & KAEL Co., Ltd Media Release
- 26 Mar 2021 According to a GemVax & KAEL media release, results from this trial published in the SCI-grade international journal Alzheimer Research & Therapy
- 23 Nov 2020 Results presented in a GemVax and KAEL Co., Ltd media release.